title: Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
authors.forename: S D
authors.initials: SD
authors.lastname: Shafran
authors.forename: J
authors.initials: J
authors.lastname: Deschênes
authors.forename: M
authors.initials: M
authors.lastname: Miller
authors.forename: P
authors.initials: P
authors.lastname: Phillips
authors.forename: E
authors.initials: E
authors.lastname: Toma
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D016470:Bacteremia / Q000188:drug therapy*; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D011446:Prospective Studies; D017828:Rifabutin / Q000008:administration & dosage / Q000009:adverse effects*; D014605:Uveitis / Q000139:chemically induced*
chemical_list: D017828:Rifabutin; D004977:Ethambutol; D017291:Clarithromycin